Home / Healthcare/ FDA clears Novo Nordisk’s diabetes drug to reduce cardiovascular risk

FDA clears Novo Nordisk’s diabetes drug to reduce cardiovascular risk

Comments / {{hitsCtrl.values.hits}} Views / Monday, 28 August 2017 00:09

Reuters: Novo Nordisk said on Friday the US Food and Drug Administration (FDA) approved an expanded use of its diabetes drug to reduce the risk of cardiovascular events such as heart attack and stroke.

1Novo Nordisk logo is seen in Bagsvaerd outside of Copenhagen, Denmark – REUTERS

This is the first time the FDA has cleared a diabetes drug for reducing risks of heart attack, stroke and cardiovascular deaths in patients with type 2 diabetes, the company said in a statement.

In December, the FDA had approved Eli Lilly and Co and Boehringer Ingelheim Pharmaceuticals Inc’s drug, Jardiance, to reduce the risk of cardiovascular death in patients with type 2 diabetes.

Novo Nordisk’s Victoza, which was approved in 2010 to treat patients with type 2 diabetes, brought in 11.5 billion Danish crown ($1.84 billion) in the first six months of 2017.

Type 2 diabetes, closely linked to obesity, accounts for more than 90% of all diabetes cases, the company said.

Victoza’s expanded label follows a successful trial that showed the drug significantly reduced the risk of cardiovascular death, non-fatal heart attack or non-fatal stroke by 13% when compared to a placebo.

Heart disease is the leading cause of death in the United States, killing about 610,000 people every year, according to the Centers for Disease Control and Prevention.

Adults with type 2 diabetes are up to four times more likely to develop cardiovascular disease, the company said.

Share This Article


1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.


Today's Columnists

Women’s bodies, masculinities and economic insecurities

Thursday, 22 March 2018

Cat’s Eye was deeply saddened to witness another wave of anti-Muslim violence, yet again, under a Government which promised to protect them from such violence. It was reported that the first round of violence in Ampara was sparked by a claim that

Strong brands can sustain shocks!

Thursday, 22 March 2018

The recent media highlighted the impact of communal violence on the tourism industry. The press conference earlier this week threw out a number as high as 10% whilst the actual cancellation was around 500 room nights around the Kandy vicinity was rep

Racism, riots, and the Sri Lankan State

Thursday, 22 March 2018

“One’s life has value so long as one attributes value to the life of others, by means of love, friendship, indignation and compassion” – Simone de Beauvoir

Why Ranil is still needed

Thursday, 22 March 2018

The Joint Opposition move to pass a vote of no-confidence in Prime Minister Ranil Wickremesinghe will come a cropper. Ranil knows that best as he has tersely told a group of opposition pollies (Australia slang for ‘politicians’), “Come on! Pres

Columnists More